Literature DB >> 9042323

Prostate specific antigen--new applications in breast and other cancers.

E P Diamandis1.   

Abstract

Prostate specific antigen was, until recently, thought to be a highly specific biochemical marker of prostatic epithelial cells which is not produced by any female tissue. We have used immunological and molecular techniques to demonstrate the presence of PSA protein or mRNA in various non-prostatic tissues. We have recently found that PSA is present in 30-40% of breast tumors and at a lower percentage in other tumors including lung, colon, ovary, liver, kidney, adrenal and paroria tumors. Others have found PSA in skin and salivary gland tumors and in normal endometrium. We found PSA in the normal breast, the milk of lactating women, breast discharge fluid and in amniotic fluid. We developed a tissue culture system that reproduces the phenomenon of PSA production by breast tumors. Using this system, we showed that PSA regulation is under the control of steroid hormones and their receptors. PSA is produced by normal, hyperplastic and malignant breast tissue and is present in all breast secretions and some other tumors. The physiological role of PSA in these tissues, fluids and tumors is currently unknown. A substrate for PSA in these tissues has not as yet been identified.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9042323

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

Review 1.  Insulin-like growth factor binding proteins (IGFBPs) in breast cancer.

Authors:  C M Perks; J M Holly
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-01       Impact factor: 2.673

2.  Diagnostic value of prostatic specific antigen in hirsute women.

Authors:  S Güllü; R Emral; M Asik; M Cesur; V Tonyukuk
Journal:  J Endocrinol Invest       Date:  2003-12       Impact factor: 4.256

Review 3.  IGF binding proteins (IGFBPs) and regulation of breast cancer biology.

Authors:  Claire M Perks; Jeff M P Holly
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-25       Impact factor: 2.673

Review 4.  Prostate-specific antigen and prostate-specific antigen derivatives as predictors of benign prostatic hyperplasia progression.

Authors:  Jonathan M Levitt; Kevin M Slawin
Journal:  Curr Urol Rep       Date:  2007-07       Impact factor: 3.092

5.  Diagnostic value of prostate-specific antigen in women with polycystic ovary syndrome.

Authors:  Farahnaz Mardanian; Nasrin Heidari
Journal:  J Res Med Sci       Date:  2011-08       Impact factor: 1.852

6.  Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer.

Authors:  J A Foekens; E P Diamandis; H Yu; M P Look; M E Meijer-van Gelder; W L van Putten; J G Klijn
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

7.  Unveiling the Link between Prostatitis and Periodontitis.

Authors:  Ramanarayana Boyapati; Chakrapani Swarna; Narasimhaswamy Devulapalli; Sahitya Sanivarapu; Kishore Kumar Katuri; Lakshmikanth Kolaparthy
Journal:  Contemp Clin Dent       Date:  2018 Oct-Dec

8.  Applicability of Nanotrap Sg as a semen detection kit before male-specific DNA profiling in sexual assaults.

Authors:  Itaru Sato; Filippo Barni; Miki Yoshiike; Cesare Rapone; Andrea Berti; Shinichi Nakaki; Kazuki Yamazaki; Fumio Ishikawa; Teruaki Iwamoto
Journal:  Int J Legal Med       Date:  2006-04-01       Impact factor: 2.791

Review 9.  Molecular diagnosis of prostate cancer.

Authors:  Eduardo I Canto; Shahrokh F Shariat; Kevin M Slawin
Journal:  Curr Urol Rep       Date:  2004-06       Impact factor: 2.862

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.